Random good picture Not show

1. Hepatology Digest: When intra-uterine transmission happens, the vaccination and hepatitis B immunoglobulin might not be functional.

2. Hepatology Digest: The liver is known as an immunologically privileged organ in solid organ transplants.

3. Hepatology Digest: Professor Xie, do you encounter metabolic syndrome in hepatitis C patients frequently?

4. Hepatology Digest: The nuclear receptors are important in cholestatic liver disease.

5. Hepatology Digest nuclear receptors are important in cholestatic liver disease.

6. Hepatology Digest: Amniotic fluid is said to contain a wide variety of useful cells. Could you comment about obtaining cells in this manner?

7. Hepatology Digest: Should both lactulose and rifaximin be combined for the primary prevention of HE?

8. As Hepatology Digest, it is a newspaper distributes in China by thousands of copies to southern Chinese hepatologist .

9. Hepatology Digest: What is your opinion of non - invasive diagnosis of cirrhosis non - invasiveinvasive?

10. Hepatology Digest: You have lots of data. How are you going to congeal this so it can be applied at a public health advisory level?Sentence dictionary

11. Hepatology Digest: Apart from genotype, HCV RNA, and steatosis, are there any other factors that affect the antiviral outcome of hepatitis C?

12. Hepatology Digest: Has there been any other trials to your knowledge looking at the benefits and drawbacks of rifaximin and lactulose?

13. Hepatology Digest: For nucleotide analogues, drug resistance is an inevitable problem.

14. Hepatology Digest: Cholestatic liver disease is a rare chronic liver disease. Would you please give us a brief introduction about its pathogenesis?

15. Hepatology Digest: A number of endogenous anti- and pro-fibrogenic factors are involved in liver fibrogenesis.

16. Hepatology Digest: Recently, the clinical trial result for the use of Etanercept for alcoholic hepatitis was published in Gastroenterology, and you were one of the authors.

17. Hepatology Digest: There is now a special interest group at the Liver Meeting that focuses on HCV.

18. Hepatology Digest: Please give us a brief introduction of the study of ubiquitination of liver disease.

19. Hepatology Digest: Would you please give us some advice on how to treat patients with Cholestatic liver disease?

20. Hepatology Digest: When intra-uterine transmission happens, the vaccination and hepatitis B immunoglobulin might not be functional. What is the incidence of this and how might we prevent it?

21. Hepatology Digest: The nuclear receptors are important in cholestatic liver disease. Would you please talk about the potential mechanisms in the treatment of cholestatic liver disease?

22. Hepatology Digest: This next question in on primary biliary cirrhosis.

23. Group of Fatty Liver and Alcoholic Liver Disease, Branch Association of Hepatology, Chinese Medical Association.

24. Lindsay KL . Introduction to therapy and hepatitis C . Hepatology, 2002 , 36 ( Suppl ) : S 114 - 120 , S 121 - 127 , S 135 - 144.